These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17555869)

  • 1. Refolding of misfolded mutant GPCR: post-translational pharmacoperone action in vitro.
    Janovick JA; Brothers SP; Cornea A; Bush E; Goulet MT; Ashton WT; Sauer DR; Haviv F; Greer J; Conn PM
    Mol Cell Endocrinol; 2007 Jun; 272(1-2):77-85. PubMed ID: 17555869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of pharmacoperones to reveal GPCR structural changes associated with constitutive activation and trafficking.
    Janovick JA; Conn PM
    Methods Enzymol; 2010; 485():277-92. PubMed ID: 21050923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human loss-of-function gonadotropin-releasing hormone receptor mutants retain wild-type receptors in the endoplasmic reticulum: molecular basis of the dominant-negative effect.
    Brothers SP; Cornea A; Janovick JA; Conn PM
    Mol Endocrinol; 2004 Jul; 18(7):1787-97. PubMed ID: 15105440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic rescue of misfolded mutants: validation of primary high throughput screens for identification of pharmacoperone drugs.
    Janovick JA; Park BS; Conn PM
    PLoS One; 2011; 6(7):e22784. PubMed ID: 21818389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target.
    Janovick JA; Maya-Nunez G; Conn PM
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3255-62. PubMed ID: 12107234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of testis function in hypogonadotropic hypogonadal mice harboring a misfolded GnRHR mutant by pharmacoperone drug therapy.
    Janovick JA; Stewart MD; Jacob D; Martin LD; Deng JM; Stewart CA; Wang Y; Cornea A; Chavali L; Lopez S; Mitalipov S; Kang E; Lee HS; Manna PR; Stocco DM; Behringer RR; Conn PM
    Proc Natl Acad Sci U S A; 2013 Dec; 110(52):21030-5. PubMed ID: 24324164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of G protein-coupled receptor trafficking by inefficient plasma membrane expression: molecular basis of an evolved strategy.
    Janovick JA; Knollman PE; Brothers SP; Ayala-Yáñez R; Aziz AS; Conn PM
    J Biol Chem; 2006 Mar; 281(13):8417-25. PubMed ID: 16446355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relations of successful pharmacologic chaperones for rescue of naturally occurring and manufactured mutants of the gonadotropin-releasing hormone receptor.
    Janovick JA; Goulet M; Bush E; Greer J; Wettlaufer DG; Conn PM
    J Pharmacol Exp Ther; 2003 May; 305(2):608-14. PubMed ID: 12606630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of action of pharmacoperone rescue of misrouted GPCR mutants: the GnRH receptor.
    Janovick JA; Patny A; Mosley R; Goulet MT; Altman MD; Rush TS; Cornea A; Conn PM
    Mol Endocrinol; 2009 Feb; 23(2):157-68. PubMed ID: 19095769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug development and the cellular quality control system.
    Conn PM; Janovick JA
    Trends Pharmacol Sci; 2009 May; 30(5):228-33. PubMed ID: 19307028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic rescue of misfolded/mistrafficked mutants: automation-friendly high-throughput assays for identification of pharmacoperone drugs of GPCRs.
    Smithson DC; Janovick JA; Conn PM
    Methods Enzymol; 2013; 521():3-16. PubMed ID: 23351731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant-negative action of disease-causing gonadotropin-releasing hormone receptor (GnRHR) mutants: a trait that potentially coevolved with decreased plasma membrane expression of GnRHR in humans.
    Leaños-Miranda A; Ulloa-Aguirre A; Ji TH; Janovick JA; Conn PM
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3360-7. PubMed ID: 12843188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs.
    Conn PM; Ulloa-Aguirre A
    Trends Endocrinol Metab; 2010 Mar; 21(3):190-7. PubMed ID: 20005736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological chaperones correct misfolded GPCRs and rescue function: protein trafficking as a therapeutic target.
    Maya-Núñez G; Ulloa-Aguirre A; Janovick JA; Conn PM
    Subcell Biochem; 2012; 63():263-89. PubMed ID: 23161143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.
    Ulloa-Aguirre A; Michael Conn P
    Recent Pat Endocr Metab Immune Drug Discov; 2011 Jan; 5(1):13-24. PubMed ID: 22074574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo.
    Conn PM; Ulloa-Aguirre A; Ito J; Janovick JA
    Pharmacol Rev; 2007 Sep; 59(3):225-50. PubMed ID: 17878512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue of misrouted GnRHR mutants reveals its constitutive activity.
    Janovick JA; Pogozheva ID; Mosberg HI; Cornea A; Conn PM
    Mol Endocrinol; 2012 Jul; 26(7):1179-88. PubMed ID: 22595961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-misrouting: an unexpectedly prevalent and rescuable etiology in gonadotropin-releasing hormone receptor-mediated hypogonadotropic hypogonadism.
    Leaños-Miranda A; Janovick JA; Conn PM
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4825-8. PubMed ID: 12364481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoperones as a New Therapeutic Approach: In Vitro Identification and In vivo Validation of Bioactive Molecules.
    Ulloa-Aguirre A; Conn PM
    Curr Drug Targets; 2016; 17(13):1471-81. PubMed ID: 26953247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors.
    Conn PM; Ulloa-Aguirre A
    Adv Pharmacol; 2011; 62():109-41. PubMed ID: 21907908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.